Literature DB >> 17005700

Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.

Pierre Delobel1, Marie-Thérèse Nugeyre, Michelle Cazabat, Karine Sandres-Sauné, Christophe Pasquier, Lise Cuzin, Bruno Marchou, Patrice Massip, Rémi Cheynier, Françoise Barré-Sinoussi, Jacques Izopet, Nicole Israël.   

Abstract

The reasons for poor CD4+ T-cell recovery in some human immunodeficiency virus (HIV)-infected subjects despite effective highly active antiretroviral therapy (HAART) remain unclear. We recently reported that CXCR4-using (X4) HIV-1 could be gradually selected in cellular reservoirs during sustained HAART. Because of the differential expression of HIV-1 coreceptors CCR5 and CXCR4 on distinct T-cell subsets, the residual replication of R5 and X4 viruses could have different impacts on T-cell homeostasis during immune reconstitution on HAART. We examined this hypothesis and the mechanisms of CD4+ T-cell restoration by comparing the virological and immunological features of 15 poor and 15 good immunological responders to HAART. We found a high frequency of X4 viruses in the poor immunological responders. But the levels of intrathymic proliferation of the two groups were similar regardless of whether they were infected by R5 or X4 virus. The frequency of recent thymic emigrants in the poor immunological responders was also similar to that found in the good immunological responders, despite their reduced numbers of naïve CD4+ T cells. Our data, rather, suggest that the naïve T-cell compartment is drained by a high rate of mature naïve cell loss in the periphery due to bystander apoptosis or activation-induced differentiation. X4 viruses could play a role in the depletion of naïve T cells in poor immunological responders to HAART by triggering persistent T-cell activation and bystander apoptosis via gp120-CXCR4 interactions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17005700      PMCID: PMC1617280          DOI: 10.1128/JVI.00965-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

Review 1.  Concomitant regulation of T-cell activation and homeostasis.

Authors:  Zvi Grossman; Booki Min; Martin Meier-Schellersheim; William E Paul
Journal:  Nat Rev Immunol       Date:  2004-05       Impact factor: 53.106

2.  Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.

Authors:  B Autran; G Carcelain; T S Li; C Blanc; D Mathez; R Tubiana; C Katlama; P Debré; J Leibowitch
Journal:  Science       Date:  1997-07-04       Impact factor: 47.728

3.  The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes.

Authors:  C C Bleul; L Wu; J A Hoxie; T A Springer; C R Mackay
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

4.  Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods.

Authors:  H Lecoeur; E Ledru; M C Prévost; M L Gougeon
Journal:  J Immunol Methods       Date:  1997-12-01       Impact factor: 2.303

5.  Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule.

Authors:  R A Fouchier; M Groenink; N A Kootstra; M Tersmette; H G Huisman; F Miedema; H Schuitemaker
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

6.  Residual human immunodeficiency virus type 1 RNA in lymphoid tissue of patients with sustained plasma RNA of <200 copies/mL.

Authors:  A Lafeuillade; L Chollet; G Hittinger; N Profizi; O Costes; C Poggi
Journal:  J Infect Dis       Date:  1998-01       Impact factor: 5.226

7.  Changes in thymic function with age and during the treatment of HIV infection.

Authors:  D C Douek; R D McFarland; P H Keiser; E A Gage; J M Massey; B F Haynes; M A Polis; A T Haase; M B Feinberg; J L Sullivan; B D Jamieson; J A Zack; L J Picker; R A Koup
Journal:  Nature       Date:  1998-12-17       Impact factor: 49.962

8.  High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection.

Authors:  J M McCune; R Loftus; D K Schmidt; P Carroll; D Webster; L B Swor-Yim; I R Francis; B H Gross; R M Grant
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

9.  Induction of simian AIDS in infant rhesus macaques infected with CCR5- or CXCR4-utilizing simian-human immunodeficiency viruses is associated with distinct lesions of the thymus.

Authors:  R A Reyes; Don R Canfield; Ursula Esser; Lourdes A Adamson; Charles R Brown; Cecilia Cheng-Mayer; Murray B Gardner; Janet M Harouse; Paul A Luciw
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status.

Authors:  Audrey L Kinter; Margaret Hennessey; Alicia Bell; Sarah Kern; Yin Lin; Marybeth Daucher; Maria Planta; Mary McGlaughlin; Robert Jackson; Steven F Ziegler; Anthony S Fauci
Journal:  J Exp Med       Date:  2004-07-26       Impact factor: 14.307

View more
  23 in total

1.  CCR6(-) regulatory T cells blunt the restoration of gut Th17 cells along the CCR6-CCL20 axis in treated HIV-1-infected individuals.

Authors:  C Loiseau; M Requena; M Mavigner; M Cazabat; N Carrere; B Suc; K Barange; L Alric; B Marchou; P Massip; J Izopet; P Delobel
Journal:  Mucosal Immunol       Date:  2016-02-17       Impact factor: 7.313

2.  Phylogenetic Analyses Comparing HIV Sequences from Plasma at Virologic Failure to Cervix Versus Blood Sequences from Antecedent Antiretroviral Therapy Suppression.

Authors:  Marta E Bull; Jennifer L McKernan; Sheila Styrchak; Kelli Kraft; Jane Hitti; Susan E Cohn; Kenneth Tapia; Wenjie Deng; Sarah Holte; James I Mullins; Robert W Coombs; Lisa M Frenkel
Journal:  AIDS Res Hum Retroviruses       Date:  2019-04-30       Impact factor: 2.205

3.  Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals.

Authors:  Maud Mavigner; Michelle Cazabat; Martine Dubois; Fatima-Ezzahra L'Faqihi; Mary Requena; Christophe Pasquier; Pascale Klopp; Jacques Amar; Laurent Alric; Karl Barange; Jean-Pierre Vinel; Bruno Marchou; Patrice Massip; Jacques Izopet; Pierre Delobel
Journal:  J Clin Invest       Date:  2011-12-12       Impact factor: 14.808

4.  A Lower Baseline CD4/CD8 T-Cell Ratio Is Independently Associated with Immunodiscordant Response to Antiretroviral Therapy in HIV-Infected Subjects.

Authors:  I Rosado-Sánchez; I Herrero-Fernández; A I Álvarez-Ríos; M Genebat; M A Abad-Carrillo; E Ruiz-Mateos; F Pulido; J González-García; M Montero; E Bernal-Morell; F Vidal; M Leal; Y M Pacheco
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

5.  Interleukin-7 receptor signaling is deficient in CD4+ T cells from HIV-infected persons and is inversely associated with aging.

Authors:  Douglas A Bazdar; Magdalena Kalinowska; Scott F Sieg
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

6.  Association between discordant immunological response to highly active anti-retroviral therapy, regulatory T cell percentage, immune cell activation and very low-level viraemia in HIV-infected patients.

Authors:  J Saison; T Ferry; J Demaret; D Maucort Boulch; F Venet; T Perpoint; F Ader; V Icard; C Chidiac; G Monneret
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

7.  Effect of baseline HIV disease parameters on CD4+ T cell recovery after antiretroviral therapy initiation in Kenyan women.

Authors:  Lyle R McKinnon; Makobu Kimani; Charles Wachihi; Nico J Nagelkerke; Festus K Muriuki; Anthony Kariri; Richard T Lester; Lawrence Gelmon; T Blake Ball; Francis A Plummer; Rupert Kaul; Joshua Kimani
Journal:  PLoS One       Date:  2010-07-02       Impact factor: 3.240

8.  Early changes in T-cell activation predict antiretroviral success in salvage therapy of HIV infection.

Authors:  Brett D Shepard; Mona R Loutfy; Janet Raboud; Frank Mandy; Colin M Kovacs; Christina Diong; Michele Bergeron; Victoria Govan; Stacey A Rizza; Jonathan B Angel; Andrew D Badley
Journal:  J Acquir Immune Defic Syndr       Date:  2008-06-01       Impact factor: 3.731

9.  Loss of naïve (CD45RA+) CD4+ lymphocytes during pediatric infection with feline immunodeficiency virus.

Authors:  Abigail D Carreño; Ayalew Mergia; Janelle Novak; Nazareth Gengozian; Calvin M Johnson
Journal:  Vet Immunol Immunopathol       Date:  2007-09-11       Impact factor: 2.046

10.  HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy.

Authors:  Maud Mavigner; Pierre Delobel; Michelle Cazabat; Martine Dubois; Fatima-Ezzahra L'faqihi-Olive; Stéphanie Raymond; Christophe Pasquier; Bruno Marchou; Patrice Massip; Jacques Izopet
Journal:  PLoS One       Date:  2009-10-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.